Page last updated: 2024-09-04

docetaxel anhydrous and rolipram

docetaxel anhydrous has been researched along with rolipram in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (rolipram)	Trials (rolipram)	Recent Studies (post-2010) (rolipram)
12,110	3,216	6,920	1,604	17	401

Protein Interaction Comparison

Protein	Taxonomy	rolipram (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	1.2233
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	Homo sapiens (human)	1.2233
Retina-specific copper amine oxidase	Homo sapiens (human)	0.0003
cGMP-specific 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	1.0975
3',5'-cyclic-AMP phosphodiesterase	Sus scrofa (pig)	3.63
Renin	Homo sapiens (human)	3.5
Tumor necrosis factor	Homo sapiens (human)	0.35
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Rattus norvegicus (Norway rat)	0.7287
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Rattus norvegicus (Norway rat)	0.7287
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Rattus norvegicus (Norway rat)	0.8447
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens (human)	1.1942
Sodium-dependent serotonin transporter	Rattus norvegicus (Norway rat)	0.095
Delta-type opioid receptor	Mus musculus (house mouse)	1.5
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	1.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Rattus norvegicus (Norway rat)	0.7287
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	Homo sapiens (human)	0.835
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	1.1005
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Homo sapiens (human)	1.61
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	1.0794
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens (human)	0.835
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens (human)	2
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	Homo sapiens (human)	0.835
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	Homo sapiens (human)	0.835
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Homo sapiens (human)	0.835

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callaghan, CK; O'Mara, SM	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and rolipram

Article	Year
Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram. Behavioural brain research, 2015, Sep-01, Volume: 290 Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Docetaxel; Male; Memory Disorders; Phosphodiesterase 4 Inhibitors; Rats; Rats, Wistar; Rolipram; Spatial Memory; Taxoids	2015

Article

Year

Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram.

Behavioural brain research, 2015, Sep-01, Volume: 290

Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Docetaxel; Male; Memory Disorders; Phosphodiesterase 4 Inhibitors; Rats; Rats, Wistar; Rolipram; Spatial Memory; Taxoids

2015